Literature DB >> 16419110

Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients.

Giuseppe Gerna1, Patrizio Vitulo, Francesca Rovida, Daniele Lilleri, Carlo Pellegrini, Tiberio Oggionni, Giulia Campanini, Fausto Baldanti, M Grazia Revello.   

Abstract

UNLABELLED: Viral respiratory tract infections in lung transplant recipients may be severe. During three consecutive winter-spring seasons, 49 symptomatic lung transplant recipients with suspected respiratory viral infection, and 26 asymptomatic patients were investigated for presence of respiratory viruses either in 56 nasopharyngeal aspirate or 72 bronchoalveolar lavage samples taken at different times after transplantation. On the whole, 1 asymptomatic (3.4%) and 28 symptomatic (57.1%) patients were positive for human metapneumovirus (hMPV, 4 patients), influenza virus A (3 patients), and B (2 patients), respiratory syncytial virus (2 patients), human coronavirus (2 patients), human parainfluenza virus (2 patients), rhinovirus (5 patients), while 4 patients were coinfected by 2 respiratory viruses, and 5 were infected sequentially by 2 or more respiratory viruses. In bronchoalveolar lavage samples, hMPV predominated by far over the other viruses, being responsible for 60% of positive specimens, whereas other viruses were present in nasopharyngeal aspirates at a comparable rate. RT-PCR (detecting 43 positive samples/128 examined) was largely superior to monoclonal antibodies (detecting 17 positive samples only). In addition, HCMV was detected in association with a respiratory virus in 4/18 HCMV-positive patients, and was found at a high concentration (>10(5) DNA copies/ml) in 3/16 (18.7%) patients with HCMV-positive bronchoalveolar lavage samples and pneumonia. Coinfections and sequential infections by HCMV and respiratory viruses were significantly more frequent in patients with acute rejection and steroid treatment. IN
CONCLUSION: (i) about 50% of respiratory tract infections of lung transplant recipients were associated with one or more respiratory viruses; (ii) hMPV largely predominates in bronchoalveolar lavage of symptomatic lung transplant recipients, thus suggesting a causative role in lower respiratory tract infections; (iii) RT-PCR appears to be the method of choice for detection of respiratory viruses in lung transplant recipients, (iv) a high HCMV load in bronchoalveolar lavage is a risk factor for viral pneumonia, suggesting some measure of intervention for the control of viral infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16419110      PMCID: PMC7166633          DOI: 10.1002/jmv.20555

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  39 in total

1.  Early detection of acute rhinovirus infections by a rapid reverse transcription-PCR assay.

Authors:  C Steininger; S W Aberle; T Popow-Kraupp
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients.

Authors:  J L Sanchez; R M Kruger; S Paranjothi; E P Trulock; J P Lynch; C Hicks; W D Shannon; G A Storch
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

3.  Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.

Authors:  T J Kroshus; V R Kshettry; K Savik; R John; M I Hertz; R M Bolman
Journal:  J Thorac Cardiovasc Surg       Date:  1997-08       Impact factor: 5.209

4.  Community respiratory viral infection in adult lung transplant recipients.

Authors:  S M Palmer; N G Henshaw; D N Howell; S E Miller; R D Davis; V F Tapson
Journal:  Chest       Date:  1998-04       Impact factor: 9.410

5.  Rapid detection of human metapneumovirus strains in nasopharyngeal aspirates and shell vial cultures by monoclonal antibodies.

Authors:  Elena Percivalle; Antonella Sarasini; Livia Visai; M Grazia Revello; Giuseppe Gerna
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

6.  The epidemiology of parainfluenza virus infection in lung transplant recipients.

Authors:  R A Vilchez; K McCurry; J Dauber; A Iacono; R Keenan; A Zeevi; B Griffith; S Kusne
Journal:  Clin Infect Dis       Date:  2001-11-08       Impact factor: 9.079

7.  Quantitative analysis of cytomegalovirus viremia in lung transplant recipients.

Authors:  T C Bailey; R S Buller; N A Ettinger; E P Trulock; M Gaudreault-Keener; T M Langlois; J E Fornoff; J D Cooper; G A Storch
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

8.  Influenza virus infection in adult solid organ transplant recipients.

Authors:  Regis A Vilchez; Kenneth McCurry; James Dauber; Aldo Lacono; Bartley Griffith; John Fung; Shimon Kusne
Journal:  Am J Transplant       Date:  2002-03       Impact factor: 8.086

9.  Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial.

Authors:  Giuseppe Gerna; Fausto Baldanti; Daniele Lilleri; Maurizio Parea; Maria Torsellini; Barbara Castiglioni; Patrizio Vitulo; Carlo Pellegrini; Mario Viganò; Paolo Grossi; Maria Grazia Revello
Journal:  Transplantation       Date:  2003-04-15       Impact factor: 4.939

10.  Adenovirus infection in the lung results in graft failure after lung transplantation.

Authors:  N D Bridges; T L Spray; M H Collins; N E Bowles; J A Towbin
Journal:  J Thorac Cardiovasc Surg       Date:  1998-10       Impact factor: 5.209

View more
  34 in total

Review 1.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

2.  Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis.

Authors:  Ryan Dare; Sonali Sanghavi; Arlene Bullotta; Maria-Cristina Keightley; Kirsten St George; Robert M Wadowsky; David L Paterson; Kenneth R McCurry; Todd A Reinhart; Shahid Husain; Charles R Rinaldo
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

3.  Long-term impact of respiratory viral infection after pediatric lung transplantation.

Authors:  M Liu; G B Mallory; M G Schecter; S Worley; S Arrigain; J Robertson; O Elidemir; L A Danziger-Isakov
Journal:  Pediatr Transplant       Date:  2010-03-04

4.  Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination.

Authors:  Susanna K P Lau; Paul Lee; Alan K L Tsang; Cyril C Y Yip; Herman Tse; Rodney A Lee; Lok-Yee So; Yu-Lung Lau; Kwok-Hung Chan; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

5.  Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection.

Authors:  Laura Gibson; Constance M Barysauskas; Margaret McManus; Sheryl Dooley; Daniele Lilleri; Donna Fisher; Tumul Srivastava; Don J Diamond; Katherine Luzuriaga
Journal:  J Clin Immunol       Date:  2015-02-25       Impact factor: 8.317

6.  Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study.

Authors:  Stuart C Sweet; Hyunsook Chin; Carol Conrad; Don Hayes; Peter S Heeger; Albert Faro; Samuel Goldfarb; Ernestina Melicoff-Portillo; Thalachallour Mohanakumar; Jonah Odim; Marc Schecter; Gregory A Storch; Gary Visner; Nikki M Williams; Karen Kesler; Lara Danziger-Isakov
Journal:  Am J Transplant       Date:  2019-07-25       Impact factor: 8.086

7.  Population-based incidence of human metapneumovirus infection among hospitalized children.

Authors:  John V Williams; Kathryn M Edwards; Geoffrey A Weinberg; Marie R Griffin; Caroline B Hall; Yuwei Zhu; Peter G Szilagyi; Chiaoyin K Wang; Chin-Fen Yang; David Silva; Dan Ye; Richard R Spaete; James E Crowe
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 8.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

9.  Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.

Authors:  Daniele Lilleri; Anna Kabanova; Antonio Lanzavecchia; Giuseppe Gerna
Journal:  J Clin Immunol       Date:  2012-07-27       Impact factor: 8.317

10.  A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.

Authors:  John V Williams; Zhifeng Chen; Gabriella Cseke; David W Wright; Christopher J Keefer; Sharon J Tollefson; Ann Hessell; Amy Podsiad; Bryan E Shepherd; Pietro Paolo Sanna; Dennis R Burton; James E Crowe; R Anthony Williamson
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.